Skip to main content

Table 1 Virus Titer Day 4 post-infection in mice inoculated with HSV-1 strain SC16 or HSV-2 strain SB5 and treated orally with Placebo, FCV or VCV

From: Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice

  

Virus Titer (log10 PFU/ear)

Virus inoculumb

Placebo

FCV

VCV

  

0.2 mg/mlc

1.0 mg/mlc

0.2 mg/mlc

1.0 mg/mlc

HSV-1 (SC16)

4.54 ± 0.04a

2.92 ± 0.23 (2.4)d

1.0 ± 0.21 (0.03)

2.45 ± 0.15 (0.80)

0.74 ± 0.35 (0.02)

HSV-2 (SB5)

4.73 ± 0.30

2.55 ± 0.25 (0.67)

0.98 ± 0.13 (0.02)

2.06 ± 0.17 (0.20)

0.72 ± 0.44 (0.01)

  1. aGeometric mean titer ± standard deviation of virus obtained from the ears of five mice and titrated independently. bA total of 105 PFU was inoculated into each ear pinna. cTreatment in the drinking water from the time of virus inoculation. Mice drank approximately 1.5 ml per day. No differences in intake volume or spillage between treatment groups were evident. dPercent virus yield compared to placebo-treated mice.